Skip to main content

DEXCOM INC

For the period ended Dec 31, 2023. Filed Feb 8, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 8, 2024

DXCM$79.92-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

DexCom, Inc.

Consolidated Statements of Cash Flows

Twelve Months EndedDecember 31,
2023 · 2022 · 2021
(In millions)
Operating activities
Net income$541.5$341.2$216.9
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization186.0155.9102.0
Share-based compensation150.8126.5113.4
Collaborative research and development fee——87.1
Loss on extinguishment of debt——0.1
Non-cash interest expense7.86.37.2
Realized (gain) loss on equity investment(1.9)(0.2)(11.6)
Deferred income taxes(55.0)(21.6)15.8
Other non-cash income and expenses(83.9)34.743.6
Changes in operating assets and liabilities:
Accounts receivable, net(260.1)(199.9)(75.5)
Inventory(252.6)49.3(112.2)
Prepaid and other assets19.3(131.6)(21.3)
Operating lease right-of-use assets and liabilities, net(4.5)(5.8)(0.1)
Accounts payable and accrued liabilities466.5295.158.0
Accrued payroll and related expenses37.28.510.4
Deferred revenue and other liabilities(2.6)11.18.7
Net cash provided by operating activities748.5669.5442.5
Investing activities
Purchase of marketable securities(3,200.4)(2,266.3)(2,473.1)
Proceeds from sale and maturity of marketable securities2,947.42,127.82,666.3
Purchases of property and equipment(236.6)(364.8)(389.2)
Acquisitions, net of cash acquired—(3.9)(30.2)
Other investing activities(17.6)(14.3)10.1
Net cash used in investing activities(507.2)(521.5)(216.1)
Financing activities
Net proceeds from issuance of common stock26.622.520.3
Purchases of treasury stock(688.7)(557.7)—
Proceeds from issuance of convertible notes, net of issuance costs1,230.6——
Purchases of capped call transactions(101.3)——
Payments for conversions of senior convertible notes(787.3)——
Other financing activities1.5(17.3)(9.9)
Net cash provided by (used in) financing activities(318.6)(552.5)10.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash1.5(5.8)(1.4)
Increase (decrease) in cash, cash equivalents and restricted cash(75.8)(410.3)235.4
Cash, cash equivalents and restricted cash, beginning of period643.31,053.6818.2
Cash, cash equivalents and restricted cash, end of period$567.5$643.3$1,053.6
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents$566.3$642.3$1,052.6
Restricted cash1.21.01.0
Total cash, cash equivalents and restricted cash$567.5$643.3$1,053.6
Twelve Months EndedDecember 31,
202320222021
Supplemental disclosure of non-cash investing and financing transactions:
Shares issued for repurchase and conversions of senior convertible notes$1,501.9$35.9$157.7
Shares received under note hedge upon conversion of 2023 Notes$(1,490.3)$(33.5)$(130.8)
Acquisition of property and equipment included in accounts payable and accrued liabilities$53.2$25.7$45.4
Supplemental cash flow information:
Cash paid during the year for interest$12.4$12.2$11.6
Cash paid during the year for income taxes$212.3$114.2$16.8
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.